Abstract
Infectious intracranial aneurysms (IIA) are rare but a considerable source of morbidity and mortality as a result of rupture. Most patients with these lesions have considerable medical comorbidities, making endovascular approaches a crucial modality in their treatment armamentarium. Contributing our own case, we performed a comprehensive review of the literature to illustrate overall results and outcomes for patients with IIA treated with endovascular approaches. Incorporating our own case, we found 65 patients harboring 72 IIA across 31 reports. Fifty-one were treated via parent artery occlusion (71 %), 17 via direct aneurysm embolization (24 %), two via stent-coiling (3 %), and two with stent monotherapy (3 %). Twenty-nine IIAs were treated with n‐butylcyanoacrylate (NBCA) (40 %), 25 with coils (35 %), seven with Onyx or ethylene vinyl alcohol (10 %), five with detachable balloons (7 %), four with stents (6 %), and one with autologous clot (1 %). One case of incomplete aneurysm occlusion and two cases of recanalization were reported. Six symptomatic periprocedural ischemic events were reported (9 %), with only three resulting in permanent sequelae (5 %). No infectious complications were reported. Incorporating the natural history of the disease, 28 patients were neurologically intact (43 %), while seven had died at the time of follow-up (11 %). Endovascular treatment of ruptured, symptomatic, or enlarging IIA is an excellent treatment modality with high occlusion rates and low procedure-related complication rates. Distal IIA are more often treated with parent artery occlusion, in our hands, preferentially with Onyx, while proximal lesions may be treated with direct stent-coiling or even flow-diverting stent monotherapy.
Similar content being viewed by others
References
Appelboom G, Kadri K, Hassan F, Leclerc X (2010) Infectious aneurysm of the cavernous carotid artery in a child treated with a new-generation of flow-diverting stent graft: case report. Neurosurgery 66:E623–E624
Asai T, Usui A, Miyachi S, Ueda Y (2002) Endovascular treatment for intracranial mycotic aneurysms prior to cardiac surgery. Eur J Cardiothorac Surg 21:948–950
Aspoas AR, de Villiers JC (1993) Bacterial intracranial aneurysms. Br J Neurosurg 7:367–376
Barrow DL, Prats AR (1990) Infectious intracranial aneurysms: comparison of groups with and without endocarditis. Neurosurgery 27:562–572
Bohmfalk GL, Story JL, Wissinger JP et al (1978) Bacterial intracranial aneurysms. J Neurosurg 48:369–382
Cantu RC, LeMay M, Wilkinson HA (1966) The importance of repeated angiography in the treatment of mycotic–embolic intracranial aneurysms. J Neurosurg 25:189–193
Chapot R, Houdart E, Saint-Maurice JP, Aymard A, Mounayer C, Lot G, Merland JJ (2002) Endovascular treatment of cerebral mycotic aneurysms. Radiology 222:389–396
Chun JY, Smith W, Halbach VV, Higashida RT, Wilson CB, Lawton MT (2001) Current multimodality management of infectious intracranial aneurysms. Neurosurgery 48:1203–1214
Clare CE, Barrow DL (1992) Infectious intracranial aneurysms. Neurosurg Clin N Am 3:551–566
Cloft HJ, Kallmes DF, Jensen ME, Lanzino G, Dion JE (1999) Endovascular treatment of ruptured, peripheral cerebral aneurysms: parent artery occlusion with short Guglielmi detachable coils. AJNR Am J Neuroradiol 20:308–310
Corr P, Wright M, Handler LC (1995) Endocarditis-related cerebral aneurysms: radiologic changes with treatment. AJNR Am J Neuroradiol 16:745–748
Day AL (1981) Extracranial intracranial bypass grafting in the surgical treatment of bacterial aneurysms: report of 2 cases. Neurosurgery 9:583–588
Dhomne S, Rao C, Shrivastava M, Sidhartha W, Limaye U (2008) Endovascular management of ruptured cerebral mycotic aneurysms. Br J Neurosurg 22:46–52
Ducruet AF, Hickman ZL, Zacharia BE, Narula R, Grobelny BT, Gorski J, Connolly ES (2010) Intracranial infectious aneurysms: a comprehensive review. Neurosurg Rev 33:37–46
Eddleman C, Nikas D, Shaibani A, Khan P, diPatri AJ, Tomita T (2007) Hydrocoil embolization in a ruptured infectious aneurysm in a pediatric patient: case report and review of the literature. Childs Nerv Syst 23:707–712
Eddleman CS, Surdell D, DiPatri A, Tomita T, Shaibani A (2008) Infectious intracranial aneurysms in the pediatric population: endovascular treatment with Onyx. Childs Nerv Syst 24:909–915
Erdogan HB, Erentug V, Bozbuga N, Goksedef D, Akinci E, Yakut C (2004) Endovascular treatment of intracerebral mycotic aneurysm. Tex Heart Inst J 31:165–167
Falagas ME, Nikou SA, Siempos II (2007) Infections related to coils used for embolization of arteries: review of the published evidence. J Vasc Interv Radiol 18:697–701
Frizzell RT, Vitek JJ, Hill DL, Fisher WS (1993) Treatment of a bacterial (mycotic) intracranial aneurysm using an endovascular approach. Neurosurgery 32:852–854
Hara Y, Hosoda K, Wada T, Kimura H, Kohmura E (2006) Endovascular treatment for an unusually large mycotic aneurysm manifesting as intracerebral hemorrhage—case report. Neurol Med Chir 46:544–547
Hurst RW, Choi IS, Persky M, Kupersmith M (1992) Mycotic aneurysms of the intracavernous carotid artery: a case report and review of the literature. Surg Neurol 37:142–146
Hurst RW, Judkins A, Bolger W, Chu A, Loevner LA (2001) Mycotic aneurysm and cerebral infarction resulting from fungal sinusitis: imaging and pathologic correlation. AJNR Am J Neuroradiol 22:858–863
Kannoth S, Iyer R, Thomas SV, Furtado SV, Rajesh BJ, Kesavadas C, Radhakrishnan VV, Sarma PS (2007) Intracranial infectious aneurysm: presentation, management and outcome. J Neurol Sci 256:3–9
Khayata M, Aymard A, Casasco A, Herbreteau D, Woimant F, Merland JJ (1993) Selective endovascular techniques in the treatment of cerebral mycotic aneurysms. J Neurosurg 78:661–665
Kojima Y, Saito A, Kim I (1989) The role of serial angiography in the management of bacterial and fungal intracranial aneurysms. Neurol Med Chir (Tokyo) 29:202–216
LaBarge DV, Ng PP, Stevens EA, Friedline NK, Kestle JR, Schmidt RH (2009) Extended intracranial applications for ethylene vinyl alcohol copolymer (Onyx): mycotic and dissecting aneurysms. J Neurosurg 111:114–118
Lasjaunias P, Wuppalapati S, Alvarez H, Rodesch G, Ozanne A (2005) Intracranial aneurysms in children aged under 15 years: review of 59 consecutive children with 75 aneurysms. Childs Nerv Syst 21:437–450
Micheli F, Schteinschnaider A, Plaghos LL, Melero M, Mattar D, Parera IC (1989) Bacterial cavernous sinus aneurysm treated by detachable balloon technique. Stroke 20:1751–1754
Misser SK, Lalloo S, Ponnusamy S (2005) Intracranial mycotic aneurysm due to infective endocarditis—successful NBCA glue embolization. South Afr Med J 95:397–404
Monsuez JJ, Vittecoq D, Rosenbaum A et al (1989) Prognosis of ruptured intracranial mycotic aneurysms: a review of 12 cases. Eur Heart J 10:821–825
Morawetz RB, Karp RB (1984) Evolution and resolution of intracranial bacterial (mycotic) aneurysms. Neurosurgery 15:43–49
Moskowitz MA, Rosenbaum AE, Tyler HR (1974) Angiographically monitored resolution of cerebral mycotic aneurysms. Neurology 24:1103–1108
Nakahara I, Taha MM, Higashi T, Iwamuro Y, Iwaasa M, Watanabe Y et al (2006) Different modalities of treatment of intracranial mycotic aneurysms: report of 4 cases. Surg Neurol 66:405–410
Ojemann RF (1988) Surgical management of bacterial intracranial aneurysms. In: Schmidek HH, Sweet WH (eds) Operative neurosurgical techniques. Grune & Stratton, Orlando, pp 997–1001
Phuong LK, Link M, Wijdicks E (2002) Management of intracranial infectious aneurysms: a series of 16 cases. Neurosurgery 51:1145–1151
Quisling SV, Mawn LA, Larson TC III (2003) Blindness associated with enlarging mycotic aneurysm after cavernous sinus thrombosis. Ophthalmology 110:2036–2039
Sarcia FB, Erdogan B, Tufan K, Cekinmez M, Kizilkilic O, Sen O, Altinors MN (2008) Endovascular treatment of primary infectious aneurysm in childhood: a case report. Turk Neurosurg 18:47–51
Scotti G, Li MH, Righi C et al (1996) Endovascular treatment of bacterial intracranial aneurysms. Neuroradiology 38:186–189
Sugg RM, Weir R, Vollmer DG, Cacayorin ED (2006) Cerebral mycotic aneurysms treated with a neuroform stent: technical case report. Neurosurgery 58:E381
Uchiyama CM, Brockmeyer DL, Cherny WB, Jacobs JJ, Walker ML (2001) Ruptured intracranial mycotic aneurysm: an unusual infectious complication following craniofacial surgery. Pediatr Neurosurg 35:94–98
Utoh J, Miyauchi Y, Goto H, Obayashi H, Hirata T (1995) Endovascular approach for an intracranial mycotic aneurysm associated with infective endocarditis. J Thorac Cardiovasc Surg 110:557–559
Van de Beek D, Rabinstein AA, Peters SG, Cloft H, Wijdicks EFM (2008) Staphylococcus endocarditis associated with infectious vasculitis and recurrent cerebral hemorrhages. Neurocrit Care 8:48–52
van Rooij WJ, Sluzewski M, Beute GN (2006) Endovascular treatment of posterior cerebral artery aneurysms. AJNR Am J Neuroradiol 27:300–305
Venkatesh SK, Phadke RV, Kalode RR, Kumar S, Jain VK (2000) Intracranial infective aneurysms presenting with hemorrhage: an analysis of angiographic findings, management and outcome. Clin Radiol 55:946–953
Watanabe A, Hirano K, Ishii R (1998) Cerebral mycotic aneurysm treated with endovascular occlusion—case report. Neurol Med Chir (Tokyo) 38:657–660
Yen PS, Teo BT, Chen SC, Chiu TL (2007) Endovascular treatment for bilateral mycotic intracavernous carotid aneurysms. Case report and review of the literature. J Neurosurg 107:868–872
Yuen T, Laidlaw JD, Mitchell P (2004) Mycotic intracavernous carotid aneurysm. J Clin Neurosci 11:771–775
Zhao PC, Li J, He M, You C (2010) Infectious intracranial aneurysm: endovascular treatment with onyx case report and review of the literature. Neurol India 58:131–134
Author information
Authors and Affiliations
Corresponding author
Additional information
Comments
Ketan R. Bulsara and Ryan Grant, New Haven, Connecticut
Thank you for the opportunity to comment on this paper. We congratulate Dr. Gross and Dr. Puri on a very well-written paper that summarizes the literature on the endovascular treatment of intracranial aneurysms. Having said that, endovascular treatment of these aneurysms is not a novel concept and has been present since at least 1989. Thus, it is not surprising that the authors only found 31 reports pertaining to 65 patients. This does not speak to the rarity of the aneurysms, but rather that there is very little new information to report about these patients.
Due to the work of our pioneers, the face of cerebrovascular neurosurgery is very different today. We are no longer in a situation where we can only offer one treatment modality for this potentially devastating pathology. The vast majority of these aneurysms will be treated through endovascular means. The outcome is better. In our generation, however, it is almost mandatory that cerebrovascular centers have proficiency in microsurgery, skull base approaches, and endovascular neurosurgery either in a single individual or in a multidisciplinary fashion. By doing so, as the authors allude, we can continue to optimize our patient outcomes by tailoring patient specific care.
Andrew F. Ducruet, Phoenix, Arizona, USA
The authors have contributed an extremely well-written systematic review of the endovascular treatment of intracranial infectious aneurysms (IIA). This represents a timely publication on an under-reported topic that stands to rapidly evolve with the continued development of endovascular technology. The lack of observed infectious complications associated with endovascular treatment of IIAs, including the few reports of stent-assisted reconstructive techniques, is particularly intriguing. It is important to remember, as acknowledged by the authors in their discussion, that a definitive understanding of the outcomes associated with endovascular treatment of IIAs awaits larger series with longer follow-up intervals.
Ralph W. König, Germany
This is a comprehensive review highlightening the different aspects of endovascular treatment of a rare vascular disease: Infectious Intracranial Aneurysms (IIA). The manuscript describes a total number of 72 IIAs in 65 patients. The literature assembled comprises manuscripts published between 1980 and 2012 and therefore reflects the ongoing progress in endovascular techniques from parent vessel occlusion with detachable balloons to vessel preserving techniques like flow diversion.
Nowadays in most IIAs (ruptured, symptomatic or growing) endovascular techniques are considered as treatment of choice due to the accompanying medical problems of those critically ill patients (sepsis, septic endocarditis). But microsurgical treatment should never be neglected especially in those cases with associated intracerebral hematoma (69% of ruptured IIAs in that series).
Simplistically two different types of IIAs exist requiring different techniques of treatment:
Cavernous ICA-Aneurysms (13%), mostly due to contiguous spread as a result of cavernous sinus thrombophlebitis or meningitis: there is some tendency towards vessel preserving techniques rather than parent vessel occlusion. Coiling, stent assisted coiling or flow diverters become more and more common in those aneurysms.
Distally located MCA (46%) or PCA aneurysms (26%) mainly due to septic emboli: These atypically located aneurysms can be treated very elegantly by selective occlusion of the aneurysm or distal parent vessel occlusion with ethylene vinyl alcohol or Onyx.
This review confirms the safety and efficacy of endovascular treatment in patients with IIAs. But due to the diversity of those infectious aneurysms different endovascular techniques have to be tailored to the individual patient and nevertheless microsurgical options should not be neglected.
Rights and permissions
About this article
Cite this article
Gross, B.A., Puri, A.S. Endovascular treatment of infectious intracranial aneurysms. Neurosurg Rev 36, 11–19 (2013). https://doi.org/10.1007/s10143-012-0414-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10143-012-0414-1